Prospective Evaluation for Receiving SynFlow 3.0 Interventional Circulatory Support in High-risk PCI: A Randomized Controlled Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bo Luan, Phd
Liaoning Provincial People's Hospital
Principal Investigator - Cheng Zhang, Phd
Qilu Hospital of Shandong University
Principal Investigator - Chuanyu Gao, Phd
Fuwai Huazhong Cardiovascular Hospital
Principal Investigator - Dan Song, Phd
Wuhan Asia Heart Hospital
Principal Investigator - Jianan Wang, Phd
Second Affiliated Hospital, School of Medicine, Zhejiang University
Principal Investigator - Jiancheng Xiu, Phd
Nanfang Hospital, Southern Medical University
Principal Investigator - Jianhong Tao, Phd
Sichuan Academy of Medical Sciences
Principal Investigator - Jingping Wang, Phd
Shanxi Cardiovascular Hospital
Principal Investigator - Junbo Ge, Phd
Shanghai Zhongshan Hospital
Study Chair - Lin Zhao, Phd
Beijing Chao Yang Hospital
Principal Investigator - Min Dai, Phd
Mianyang Central Hospital
Principal Investigator - Ming Bai, Phd
LanZhou University
Principal Investigator - Renqiang Yang, Phd
Second Affiliated Hospital of Nanchang University
Principal Investigator - Yan Li, Phd
The Second Affiliated Hospital of Air Force Military Medical University
Principal Investigator - Yan Wang
Xiamen Cardiovascular Hospital
Principal Investigator - Yansong Guo, Phd
Fujian Provincial Hospital
Principal Investigator - Yining Yang, Phd
People's Hospital of Xinjiang Uygur Autonomous Region
Principal Investigator - Yundai Chen, Phd
First Medical Center of the General Hospital of the People's Liberation Army
Study Chair - Zuyi Yuan, Phd
First Affiliated Hospital Xi'an Jiaotong University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Zhongshan Hospital Affiliated To Fudan University
Shanghai, Shanghai Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Sept 2024
- Primary completion
- 27 May 2025
- Completion
- 13 Aug 2025
- Last update posted
- 29 Aug 2025
- Registered enrollment
- 222
- Registry id
- NCT06853470
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.